Kitenge M, Laxmeshwar C, Bermudez-Aza EH, Ford-Kamara E, van Custem G, et al.
2022-03-30 • PLOS One
2022-03-30 • PLOS One
BACKGROUND Innovative models to distribute oral HIV self-tests (HIVST) provide an opportunity to increase access to HIV testing, especially for hard-to-reach populations. This study ...
Mesic A, Ishaq S, Khan WH, Mureed A, Mar HT, et al.
2022-01-03 • Tropical Medicine and International Health
2022-01-03 • Tropical Medicine and International Health
OBJECTIVES To describe the effect of adaptations to a person-centred care with short oral regimens on retention in care for rifampicin-resistant TB (RR-TB) in Kandahar province, Afgh...
Hacking D, Cassidy T, Ellman T, Steele SJ, Moore HA, et al.
2022-03-02 • AIDS and Behavior
2022-03-02 • AIDS and Behavior
In South Africa, where an estimated 34% of nearly 7-million HIV-positive people were not on antiretroviral therapy (ART) in 2019, innovative strategies to diagnose and link people to car...
Mesic A, Decroo T, Mar HT, Jacobs BKM, Thandar MP, et al.
2022-07-29 • PLOS One
2022-07-29 • PLOS One
INTRODUCTION Despite HIV viral load (VL) monitoring being serial, most studies use a cross-sectional design to evaluate the virological status of a cohort. The objective of our study...
Nair P, Hasan T, Zaw KK, Allamuratova S, Ismailov A, et al.
2022-07-01 • International Journal of Tuberculosis and Lung Disease
2022-07-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND The WHO recommends the use of bedaquiline (BDQ) in longer, as well as shorter, multidrug-resistant TB (MDR-TB) treatment regimens. However, resistance to this new drug is ...
Bermudez-Aza EH, Shetty S, Ousley J, Kyaw NTT, Soe TT, et al.
2018-02-08 • PLOS One
2018-02-08 • PLOS One
OBJECTIVE To study the long-term clinical, immunological and virological outcomes among people living with HIV on antiretroviral therapy (ART) in Myanmar.
